FDA Drug Application (201635) for TROKENDI XR by SUPERNUS PHARMS

Back to FDA Applications sponsored by SUPERNUS PHARMS

Application Number201635
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTROKENDI XR
Active IngredientTOPIRAMATE



Back to FDA Applications sponsored by SUPERNUS PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.